Clinical Utility of Subjective Memory Assessment in Multiple Sclerosis

被引：0
|
作者：
Krch, D.
Sumowski, J. F.
Chiaravalloti, N.
Deluca, J.
机构：
来源：
CLINICAL NEUROPSYCHOLOGIST | 2010年 / 24卷 / 05期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：925 / 925
页数：1
相关论文
共 50 条
  • [21] Epidemiology and clinical assessment of spasticity in multiple sclerosis
    Bensmail, D.
    Vermersch, P.
    REVUE NEUROLOGIQUE, 2012, 168 : S45 - S50
  • [22] A clinical screening tool for objective and subjective cognitive disorders in multiple sclerosis
    Guilloton, Laurent
    Camdessanche, Jean-Philippe
    Latombe, Dominique
    Neuschwander, Philippe
    Cantalloube, Sylvie
    Thomas-Anterion, Catherine
    Mercier, Bernadette
    Roggerone, Stephanie
    Maucort-Boulch, Delphine
    Roche, Sylvain
    Jacquin-Courtois, Sophie
    ANNALS OF PHYSICAL AND REHABILITATION MEDICINE, 2020, 63 (02) : 116 - 122
  • [23] Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation
    Ernst, A.
    Blanc, F.
    Voltzenlogel, V.
    de Seze, J.
    Chauvin, B.
    Manning, L.
    NEUROPSYCHOLOGICAL REHABILITATION, 2013, 23 (02) : 161 - 181
  • [24] Cognitive relapse in the absence of new neurological symptoms: clinical utility of neuropsychological assessment in a case with juvenile multiple sclerosis
    Penner, I. K.
    Hubacher, M.
    Rasenack, M.
    Sprenger, T.
    Weber, P.
    Naegelin, Y.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 303 - 303
  • [25] Nonverbal Memory Assessment with Designs: Construct Validity and Clinical Utility
    Jennifer Moye
    Neuropsychology Review, 1997, 7 : 157 - 170
  • [26] Nonverbal memory assessment with designs: Construct validity and clinical utility
    Moye, J
    NEUROPSYCHOLOGY REVIEW, 1997, 7 (04) : 157 - 170
  • [27] Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets
    Gasperini, Claudio
    Ruggieri, Serena
    Pozzilli, Carlo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 391 - 399
  • [28] Patient experience and practice trends in multiple sclerosis - clinical utility of fingolimod
    Lee, Jong-Mi
    Han, May H.
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 685 - 693
  • [29] Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis
    Fernandez, Oscar
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2012, 4 : 117 - 133
  • [30] Emerging treatment options for spasticity in multiple sclerosis - clinical utility of cannabinoids
    Ashton, John C.
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2011, 1 : 15 - 23
12345